Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1

A Lumiaho1, R Ikäheimo, R Miettinen

  • 1Department of Medicine, Kuopio University Hospital, Finland. anne.lumiaho@kuh.fi

Insights

Mitral valve prolapse is common in patients with polycystic kidney disease type 1 (PKD1). Other cardiac issues like mitral regurgitation and left ventricular hypertrophy in PKD1 patients are linked to high blood pressure.

Area of Science:

  • Cardiology
  • Nephrology
  • Genetics

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is associated with cardiac valve abnormalities.
  • The prevalence of cardiac issues in patients with a specific genotype of ADPKD (PKD1) remains underreported.

Purpose of the Study:

  • To investigate the prevalence of cardiac abnormalities in patients with polycystic kidney disease type 1 (PKD1).
  • To compare cardiac findings in PKD1 patients with unaffected family members and healthy controls.

Main Methods:

  • M-mode and color Doppler echocardiography were used.
  • 109 patients with PKD1, 73 unaffected relatives, and 73 healthy controls were studied.

Main Results:

  • Mitral valve prolapse was significantly more common in PKD1 patients (26%) compared to controls (10%).
  • Hemodynamically significant mitral regurgitation (13%) and left ventricular hypertrophy (19%) were also more prevalent in PKD1 patients.
  • Elevated blood pressure and kidney disease severity correlated with mitral regurgitation and left ventricular hypertrophy in PKD1 patients.

Conclusions:

  • Mitral valve prolapse is a characteristic cardiac finding in PKD1 patients.
  • Mitral regurgitation and left ventricular hypertrophy in PKD1 are likely secondary to hypertension.
  • Cardiac abnormalities did not differ between unaffected relatives and healthy controls.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...